logo nano spa 1

demo resto

demo resto

  • Home
  • Nanobiotechnology
  • Publications
  1. Recent advances in uveal melanoma treatment. Beatriz Álvarez‐Rodríguez, Alfonso Latorre, Christian Posch, Álvaro Somoza. Med Res Rev. 2017;00:1-21. https://doi.org/10.1002/med.21460.

  2. Self-assembly of repeat proteins: Concepts and design of new interfaces. Sanchez-deAlcazar D, Mejias SH, Erazo K, Sot B, Cortajarena AL. J Struct Biol. 2017 pii: S1047-8477(17)30142-9. doi: 10.1016/j.jsb.2017.09.002.

  3. Domain topology of human Rasal. Cuellar J, Valpuesta JM, Wittinghofer A, Sot B. Biol Chem. 2017 pii: /j/bchm.just-accepted/hsz-2017-0159/hsz-2017-0159.xml. doi: 10.1515/hsz-2017-0159.

  4. The chaperonin CCT inhibits assembly of α-synuclein amyloid fibrils by a specific, conformation-dependent interaction. Sot B, Rubio-Muñoz A, Leal-Quintero A, Martínez-Sabando J, Marcilla M, Roodveldt C, Valpuesta JM. Sci Rep. 2017;7:40859. doi: 10.1038/srep40859.

  5. Antibacterial Activity of DNA-Stabilized Silver Nanoclusters Tuned by Oligonucleotide Sequence . Siamak Javani, Romina Lorca, Alfonso Latorre, Cristina Flors, Aitziber L. Cortajarena, and Álvaro Somoza . ACS Appl. Mater. Interfaces, 2016, 8, 10147–10154.

  6. Modified RNAs in CRISPR/Cas9: An Old Trick Works Again. Alfonso Latorre, Ana Latorre, Álvaro Somoza, Angew. Chem. In. Ed. 2016, 55, 3548–3550.

  7. Molecular chaperones: functional mechanisms and nanotechnological applications. Fernández-Fernández MR, Sot B, Valpuesta JM. Nanotechnology. 2016;27(32):324004. doi: 10.1088/0957-4484/27/32/324004. Epub 2016 Jul 1. PMID: 27363314

  8. Designed modular proteins as scaffolds to stabilize fluorescent nanoclusters. Pierre Couleaud, Sergio Adan-Bermudez, Antonio Aires, Sara H Mejías, Begoña Sot, Alvaro Somoza, Aitziber L Cortajarena, Biomacromolecules 2015, 16, 3836-3844.

  9. Detection of GNAQ Mutations and Reduction of Cell Viability in Uveal Melanoma Cells with Functionalized Gold Nanoparticles. Christian Posch, Alfonso Latorre, Michelle B. Crosby, Anna Celli, Ana Latorre, Igor Vujic, Martina Sanlorenzo, Gary A. Green, Jingly Weier, Mitchell Zekhtser, Jeffrey Ma, Gabriela Monico, Devron H. Char, Denis Jusufbegovic, Klemens,Rappersberger, Álvaro Somoza, Susana Ortiz-Urda, Biomedical Microdevices 2015, 17, 1-9.

  10. Glutathione-Triggered Drug Release From Nanostructures. Alfonso Latorre, Álvaro Somoza, Current Topics in Medicinal Chemistry 2014, 14, 2662-2671.

  11. Multifunctionalization of magnetic nanoparticles for controlled drug release: a general approach. Alfonso Latorre, Pierre Couleaud, Antonio Aires, Aitziber L. Cortajarena, Álvaro Somoza, Eur. J. Med. Chem. 2014, 82, 355–362.

  12. DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. Alfonso Latorre, Christian Posch, Yolanda Garcimartín, Susana Ortiz-Urda, Álvaro Somoza, Nanoscale 2014, 6, 7436–7442.

  13. Controlled nanometric fibers of self-assembled designed protein scaffolds. Mejías SH, Sot B, Guantes R, Cortajarena AL., Nanoscale. 2014; 6(19):10982-8. doi: 10.1039/c4nr01210k.

  14. Single-point mutation detection in RNA extracts using gold nanoparticles modified with hydrophobic molecular beacon-like structures.

    Alfonso Latorre, Christian Posch, Yolanda Garcimartín, Susana Ortiz-Urda, Álvaro Somoza.,Chem. Commun., 2014,50, 3018-3020

  15. Ras GTPase activating (RasGAP) activity of the dual specificity GAP protein Rasal requires colocalization and C2 domain binding to lipid membranes. Sot B, Behrmann E, Raunser S, Wittinghofer A. Proc Natl Acad Sci U S A. 2013; 110(1):111-6. doi: 10.1073/pnas.1201658110.